Aceragen, Inc.
ACGNDelisted Aug 16, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000861838
Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Aceragen, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +1 vs. Q1 2023
- Shares held
- 165.4K
- −2.71K (−1.6%) vs. Q1 2023
- Total value
- $269.5K
- −$115.2K (−29.9%) vs. Q1 2023
- New holders
- 1
- 6 more added
- Sold out
- 0
- 3 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 3 | $0 |
| Q1 2024 | 3 | $0 |
| Q4 2023 | 3 | $0 |
| Q3 2023 | 3 | $22 |
| Q2 2023 | 20 | $269.5K |
| Q1 2023 | 19 | $384.8K |
| Q4 2022 | 32 | $1.13M |
| Q3 2022 | 34 | $1.30M |
| Q2 2022 | 33 | $1.65M |
| Q1 2022 | 31 | $1.86M |
| Q4 2021 | 34 | $2.42M |
| Q3 2021 | 47 | $6.39M |
| Q2 2021 | 48 | $7.60M |
| Q1 2021 | 57 | $12.8M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Aceragen, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 74,170 | $120.9K | 0.00% | −1,888−2.5% | Reduced |
| BlackRock Inc. | 25,214 | $41.1K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 23,342 | $38.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 11,653 | $19.0K | 0.00% | 00.0% | Unchanged |
| Credit Agricole S A | 11,521 | $18.8K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,126 | $11.6K | 0.00% | +971+15.8% | Added |
| Morgan Stanley | 4,860 | $7.92K | 0.00% | +5+0.1% | Added |
| Hollencrest Capital Management | 3,999 | $6.52K | 0.00% | −3,588−47.3% | Reduced |
| UBS Group AG | 1,709 | $2.79K | 0.00% | +1,645+2,570.3% | Added |
| Group One Trading, L.P. | 1,047 | $1.71K | 0.00% | −196−15.8% | Reduced |
| Caldwell Sutter Capital, Inc. | 294 | $479 | 0.00% | +294 | New |
| The PNC Financial Services Group, Inc. | 191 | $311 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 58 | $95 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 58 | $95 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 36 | $59 | 0.00% | +1+2.9% | Added |
| Advisor Group Holdings, Inc. | 30 | $48 | 0.00% | +29+2,900.0% | Added |
| FMR LLC | 25 | $41 | 0.00% | +19+316.7% | Added |
| Signaturefd, LLC | 11 | $18 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 10 | $16 | 0.00% | 00.0% | Unchanged |
| NewSquare Capital LLC | 4 | $7 | 0.00% | 00.0% | Unchanged |